RCKT earnings: a negative outcome, -5.5%

On May 6, 2022, Rocket Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.5% in the window around the event. It had already run -33.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.